Bone Biologics Corp Common Stock
Symbol: BBLG (NASDAQ)
2.40
▼ (-2.24%) -0.055
Company Description:
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Key Stats
- Today's Open: $2.395
- Today's High: $2.395
- Today's Low: $2.386
- Today's Volume: 54
- Yesterday Close: $2.45
- Yesterday High: $2.5
- Yesterday Low: $2.38
- Yesterday Volume: 15.42K
- Last Min Volume: 1
- Last Min High: $2.395
- Last Min Low: $2.395
- Last Min VWAP: $2.395
Company Profile
- Name: Bone Biologics Corp Common Stock
- Website: https://www.bonebiologics.com
- Listed Date: 2015-11-27
- Location: BURLINGTON, MA
- Market Status: Active
- CIK Number: 0001419554
- SIC Code: 3842
- SIC description: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Market Cap: $4.44M
- Round Lot: 100
- Outstanding Shares: 1.80M
- Asset Type: CS
RECENT FILINGS FOR BBLG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | S-8 | View |
| 2025-09-04 | 8-K | View |
| 2025-09-02 | EFFECT | View |
| 2025-08-29 | CORRESP | View |
| 2025-08-29 | S-3/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-03 | SCHEDULE 13G | View |
| 2025-07-01 | UPLOAD | View |
| 2025-06-30 | 8-K | View |
| 2025-06-30 | 424B4 | View |
| 2025-06-27 | EFFECT | View |
| 2025-06-26 | 8-K | View |
| 2025-06-24 | CORRESP | View |
| 2025-06-24 | S-3 | View |
| 2025-06-24 | S-1 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 8-K | View |
Latest News on BBLG